Recently, single-sample gene set enrichment analysis showed that, in malignant gliomas with the poorest prognosis, LGALS1—which encodes galectin-1, a β-galactoside-binding protein with immunosuppressive characteristics—is highly upregulated in association with PTEN and EGFR mutations. The gene discussed is LGALS1; the disease is malignant glioma.